We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+9.45%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$184M
AUM Growth
+$6.36M
Cap. Flow
+$4.55M
Cap. Flow %
2.48%
Top 10 Hldgs %
55.58%
Holding
70
New
31
Increased
7
Reduced
6
Closed
25

Top Buys

Rank Stock Value
1
NEE.PRV
NextEra Energy Inc 7.375% Corporate Units
NEE.PRV
+$15M
2
NRG icon
NRG Energy
NRG
+$13.4M
3
FPS
Forgent Power Solutions
FPS
+$11.6M
4
PPLC
PPL Corp Corporate Units
PPLC
+$5.15M
5
ORCL.PRD
Oracle Corp Preferred Stock Series D
ORCL.PRD
+$4.73M

Top Sells

Rank Stock Value
1
GPCR icon
Structure Therapeutics
GPCR
+$12M
2
SOFI icon
SoFi Technologies
SOFI
+$10.5M
3
ULS icon
UL Solutions
ULS
+$10.3M
4
INSM icon
Insmed
INSM
+$8.7M
5
MIAX
Miami International Holdings
MIAX
+$7.77M

Sector Composition

Rank Sector Weight
1 Healthcare 48.67%
2 Technology 8.84%
3 Industrials 8.07%
4 Utilities 7.87%
5 Financials 2.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TERN
1
DELISTED
Terns Pharmaceuticals
TERN
$15.8M 8.6%
300,000
+102,687
+52% +$4.22M
NEE.PRV
2
NextEra Energy Inc 7.375% Corporate Units
NEE.PRV
$15.2M 8.28%
+299,970
New +$15M
MDLN
3
Medline Inc
MDLN
$32.9B
$13.3M 7.26%
300,000
– –
NRG icon
4
NRG Energy
NRG
$30.3B
$12.4M 6.76%
+85,000
New +$13.4M
FPS
5
Forgent Power Solutions
FPS
$9.56B
$10.2M 5.57%
+350,000
New +$11.6M
SLDB icon
6
Solid Biosciences
SLDB
$778M
$10.2M 5.56%
1,420,295
+70,524
+5% +$453K
NKTR icon
7
Nektar Therapeutics
NKTR
$2.39B
$7.2M 3.91%
100,000
+5,866
+6% +$334K
CYTK icon
8
Cytokinetics
CYTK
$11.2B
$6.59M 3.59%
100,000
+25,000
+33% +$1.59M
PPLC
9
PPL Corp Corporate Units
PPLC
$5.24M 2.85%
+101,300
New +$5.15M
BBIO icon
10
BridgeBio Pharma
BBIO
$16.5B
$4.99M 2.71%
67,139
-32,861
-33% -$2.38M
ADT icon
11
ADT
ADT
$5.1B
$4.6M 2.5%
700,000
+300,000
+75% +$2.25M
ORCL.PRD
12
Oracle Corp Preferred Stock Series D
ORCL.PRD
$4.5M 2.45%
+100,000
New +$4.73M
EVMN
13
Evommune Inc
EVMN
$403M
$4.12M 2.24%
179,340
-3,899
-2% -$88.1K
KKR.PRD
14
KKR & Co 6.25% Series D Preferred Stock
KKR.PRD
$2.16B
$4.02M 2.19%
+100,000
New +$4.52M
ASTS icon
15
AST SpaceMobile
ASTS
$17B
$3.73M 2.03%
+45,000
New +$4.25M
SNDK
16
Sandisk
SNDK
$220B
$3.18M 1.73%
+5,000
New +$2.82M
MANE
17
Veradermics Inc
MANE
$4.82B
$3.16M 1.72%
+50,000
New +$2.52M
ZBIO
18
Zenas BioPharma
ZBIO
$1.95B
$2.93M 1.6%
+150,000
New +$3.37M
KYMR icon
19
Kymera Therapeutics
KYMR
$9.09B
$2.92M 1.59%
35,100
-64,900
-65% -$5.14M
AMBQ
20
Ambiq Micro
AMBQ
$1.7B
$2.64M 1.43%
103,756
+18,667
+22% +$557K
MMED
21
MiniMed Group Inc
MMED
$4.61B
$2.61M 1.42%
+175,000
New +$2.89M
FIGR
22
Figure Technology Solutions
FIGR
$6.3B
$2.6M 1.41%
+76,520
New +$3.3M
SGP
23
SpyGlass Pharma
SGP
$718M
$2.46M 1.34%
+95,000
New +$2.56M
GPCR icon
24
Structure Therapeutics
GPCR
$3.57B
$2.41M 1.31%
50,000
-175,000
-78% -$12M
CRSP icon
25
CRISPR Therapeutics
CRSP
$4.62B
$2.38M 1.29%
+50,000
New +$2.64M
1
2 3

Similar funds

EFIC
Eliot Finkel Investment Counsel Beverly Hills, California $184M AUM 33.43% 1-Year Est. Return
SWMG
Sard Wealth Management Group Atlanta, Georgia $184M AUM 11.26% 1-Year Est. Return
AAM
Ameraudi Asset Management New York $184M AUM 15.4% 1-Year Est. Return
IFPL
Investments & Financial Planning LLC Lexington, Kentucky $184M AUM 17.7% 1-Year Est. Return
RFG
RFP Financial Group Atlanta, Georgia $184M AUM 16.06% 1-Year Est. Return
KA
Kure Advisory Plymouth, Minnesota $184M AUM 16.02% 1-Year Est. Return
KWM
KMT Wealth Management El Segundo, California $184M AUM 17.2% 1-Year Est. Return
NAM
Nutshell Asset Management Sevenoaks, United Kingdom $184M AUM 2.02% 1-Year Est. Return

Monashee Investment Management's Q1 2026 Portfolio in Review

As of Q1 2026, Monashee Investment Management held 70 positions worth $184M, up 3.6% from $177M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Monashee Investment Management's Q1 2026 filing shows 31 new, 7 increased, 6 reduced and 25 closed positions. Its largest new stake was NextEra Energy Inc 7.375% Corporate Units: 299,970 shares worth $15.2M. The largest sale was Structure Therapeutics, an estimated $12M.

By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 63% a quarter earlier, followed by Technology and Industrials.

  • Monashee Investment Management's largest Q1 2026 buy was NextEra Energy Inc 7.375% Corporate Units: 299,970 shares worth $15.2M.
  • Monashee Investment Management added most to Terns Pharmaceuticals in Q1 2026, an estimated $4.22M increase.
  • Monashee Investment Management's biggest Q1 2026 reduction was Structure Therapeutics, cutting an estimated $12M.
  • Monashee Investment Management fully exited SoFi Technologies in Q1 2026, selling an estimated $10.5M.
  • Monashee Investment Management's ten largest holdings make up 56% of its $184M portfolio in Q1 2026.
  • Monashee Investment Management opened 31 new positions and closed 25 in Q1 2026.
  • Monashee Investment Management's portfolio value rose 3.6% quarter-over-quarter to $184M.

Based on Monashee Investment Management's 13F filing for Q1 2026, filed 13 May 2026.